Malaria

Professor Marcel Tanner

Director of the Swiss Tropical and Public Health Institute, Basel, Switzerland

Marcel Tanner obtained a PhD on medical biology from the University of Basel and a MPH from the University of London. He is Director of the Swiss Tropical and Public Health Institute and Professor of Epidemiology and Medical Parasitology at the University of Basel and at the Federal Institute of Technology. Since 1977 his research has ranged from basic research on the cell biology and immunology of malaria, schistosomiasis, trypanosomiasis and filariasis to epidemiological and public health research on risk assessment, vulnerability, health impact and district health planning. His research, teaching, and health planning expertise are based on substantial long term experience from working in rural and urban areas in Africa (mainly the United Republic of Tanzania, Chad, Burkina Faso and Côte d’Ivoire) and Asia (China, Thailand, Laos).

He was co-investigator and coordinator of the first African malaria vaccine trial in 1992 and participated as co-principal investigator in several major intervention trials on malaria (iron supplementation, intermittent preventive treatment) and schistosomiasis. Besides research, capacity building and North-South partnerships are a main interest as reflected in the development of the Ifakara Health Institute in the United Republic of Tanzania. He has published extensively in many fields (>500 original papers). He has also acted and continues to act as an advisor on communicable disease research and control, health systems strengthening and capacity building in various national and international agencies/bodies and on boards/committees such as WHO/STAC-TDR, Wellcome Trust, DNDi, NITD, INCLEN-Trust and INDEPTH.

Last updated: 15 December 2011

Share